Cargando…
Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics
Gene replacement therapy with oncosuppressor microRNAs (miRNAs) is a promising alternative to interfere with cancer progression. However, miRNAs are highly inefficient in a biological environment, hampering a successful translation to clinics. Nanotechnology can tackle this drawback by providing del...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076701/ https://www.ncbi.nlm.nih.gov/pubmed/32098309 http://dx.doi.org/10.3390/pharmaceutics12020189 |